MSGR
Direxion mRNA ETF
MSGR
MSGR
Delisted
MSGR was delisted on the 21st of April, 2023.
4 hedge funds and large institutions have $1.94M invested in Direxion mRNA ETF in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$594K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$594K |
| 3 |
Citigroup
New York
|
+$594K |
| 4 |
JPMorgan Chase & Co
New York
|
+$160K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $594K | +$594K | +25,000 | New |
|
|
2
Bank of America
Charlotte,
North Carolina
| $594K | +$594K | +25,000 | New |
|
|
3
Citigroup
New York
| $594K | +$594K | +25,000 | New |
|
|
4
JPMorgan Chase & Co
New York
| $160K | +$160K | +6,729 | New |
|